Guerrero-López Rosa, Manguán-García Cristina, Carrascoso-Rubio Carlos, Lozano M Luz, Toldos-Torres Marta, García-Castro Laura, Sánchez-Dominguez Rebeca, Alberquilla Omaira, Sánchez-Pérez Isabel, Molina-Molina Maria, Bueren Juan A, Guenechea Guillermo, Perona Rosario, Sastre Leandro
Instituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain.
Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.
Sci Rep. 2025 Feb 19;15(1):6102. doi: 10.1038/s41598-025-90246-2.
Telomeres are terminal protective chromosome structures. Genetic variants in genes coding for proteins required for telomere maintenance cause rare, life-threatening Telomere Biology Disorders (TBDs) such as dyskeratosis congenita, aplastic anemia or pulmonary fibrosis. The more frequently used mice strains have telomeres much longer than the human ones which question their use as in vivo models for TBDs. One mice model with shorter telomeres based on the CAST/EiJ mouse strain carrying a mutation in the Terc gene, coding for the telomerase RNA component, has been studied in comparison with C57BL/6J mice, carrying the same mutation and long telomeres. The possible alterations produced in lungs and the haematopoietic system, frequently affected in TBD patients, were determined at different ages of the mice. Homozygous mutant mice presented a very shortened life span, more notorious in the short-telomeres CAST/EiJ strain. The lungs of mutant mice presented a transitory increase in fibrosis and a significant decrease in the relative amount of the alveolar epithelial type 2 cells from six months of age. This decrease was larger in mutant homozygous animals but was also observed in heterozygous animals. On the contrary the expression of the senescence-related protein P21 increased from six months of age in mutant mice of both strains. The analysis of the haematopoietic system indicated a decrease in the number of megakaryocyte-erythroid progenitors in homozygous mutants and an increase in the clonogenic potential of bone marrow and LSK cells. Bone marrow cells from homozygous mutant animals presented decreasing in vitro expansion capacity. The alterations observed are compatible with precocious ageing of lung alveolar cells and the bone marrow cells that correlate with the alterations observed in TBD patients. The alterations seem to be more related to the genotype of the animals that to the basal telomere length of the strains although they are more pronounced in the short-telomere CAST/EiJ-derived strain than in C57BL/6J animals. Therefore, both animal models, at ages over 6-8 months, could represent valuable and convenient models for the study of TBDs and for the assay of new therapeutic products.
端粒是染色体末端的保护结构。编码端粒维持所需蛋白质的基因中的遗传变异会导致罕见的、危及生命的端粒生物学障碍(TBDs),如先天性角化不良、再生障碍性贫血或肺纤维化。常用的小鼠品系的端粒比人类的长得多,这使得它们作为TBDs体内模型的用途受到质疑。一种基于携带Terc基因突变的CAST/EiJ小鼠品系的端粒较短的小鼠模型,与携带相同突变和长端粒的C57BL/6J小鼠进行了比较研究。在小鼠的不同年龄阶段,确定了在TBD患者中经常受影响的肺和造血系统可能产生的改变。纯合突变小鼠的寿命非常短,在短端粒的CAST/EiJ品系中更为明显。突变小鼠的肺从6个月大时开始出现纤维化的短暂增加,以及肺泡Ⅱ型上皮细胞相对数量的显著减少。这种减少在纯合突变动物中更大,但在杂合动物中也观察到。相反,两种品系的突变小鼠从6个月大时起衰老相关蛋白P21的表达增加。造血系统分析表明,纯合突变体中的巨核细胞-红系祖细胞数量减少,骨髓和LSK细胞的克隆形成潜力增加。纯合突变动物的骨髓细胞体外扩增能力下降。观察到的改变与肺泡细胞和骨髓细胞的早衰相一致,这与在TBD患者中观察到的改变相关。这些改变似乎与动物的基因型比与品系的基础端粒长度更相关,尽管它们在源自短端粒CAST/EiJ的品系中比在C57BL/6J动物中更明显。因此,这两种动物模型在6 - 8个月以上的年龄阶段,可能代表了用于研究TBDs和检测新治疗产品的有价值且方便的模型。